MetLife (NYSE:MET), the biggest life insurance coverage firm within the U.S., has seen its inventory achieve 28% over the past 12 months, in comparison with a 23% return within the S&P500 index over the identical interval. Notably, MetLife’s peer Prudential Financial (NYSE: PRU) is up 19% over the identical interval. So what are a number of the traits driving MET inventory and what’s the outlook like?
The insurance coverage large posted a weaker-than-expected set of Q3 outcomes. Adjusted working revenues declined 3.4% year-over-year to $17.6 billion as Premiums, charges and different revenues declined by about 5% in comparison with the final 12 months, whereas funding associated earnings rose 8%. Adjusted earnings got here in at $1.93 per share. The decline in earnings was partly as a result of greater bills, which rose 7.3% 12 months over 12 months on account of upper curiosity credited to the policyholder account balances. The corporate’s group advantages enterprise was a weak performer over the past quarter. The section which provides well being, dental, life, and different insurance coverage merchandise to organizations for his or her staff has been a supply of weak point as a result of weaker non-medical well being underwriting in addition to its annual actuarial assumption evaluate.
Whereas MET inventory has seen combined progress over current years, the Trefis High Quality (HQ) Portfolio, with a set of 30 shares, has supplied higher returns with much less danger versus the benchmark S&P 500 index over the past 4 years; much less of a roller-coaster trip as evident in HQ Portfolio efficiency metrics. So is MetLife inventory engaging at present ranges?
There are a few traits that would assist MetLife inventory within the near-term. For one, the U.S. Fed has indicated that it may take a slower path towards financial easing. This could profit MetLife as in contrast to automotive or normal insurers, who depend on shorter-term insurance policies and underwriting earnings, life insurers are extra delicate to charges as a result of their long-term bond-heavy funding methods. Furthermore, the election of Donald Trump to the U.S. presidency may benefit insurers like MetLife, as probably decrease regulatory burden and tax reductions may enhance profitability. The corporate has been rising its dividend yield and its sturdy share buyback program may additionally assist drive features in the long term. General, at its present worth of $82 per share, MET is buying and selling 5% beneath the Trefis’ estimate for MetLife’s valuation of about $86 per share.
| Returns | Jan 2025 MTD [1] |
Since begin of 2024 [1] |
2017-25 Whole [2] |
| MET Return | 0% | 28% | 124% |
| S&P 500 Return | 0% | 23% | 163% |
| Trefis Strengthened Worth Portfolio | 0% | 16% | 748% |
[1] Returns as of 1/2/2025
[2] Cumulative whole returns because the finish of 2016
Make investments with Trefis Market-Beating Portfolios
See all Trefis Price Estimates
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially mirror these of Nasdaq, Inc.
